GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

I t’s not just officially cold and flu season, it’s RSV season. RSV, which stands for respiratory syncytial virus, is a highly contagious illness that affects people of all ag ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the ...

Though most people will experience the virus before age two, it is most dangerous to a few different ... Doctors recommend that adults aged 75 or older should look into a single dose of the RSV ...

The federal government will place RSV vaccines on the national immunisation program, as 12,000 babies are hospitalised with ...

The RSV vaccine leads to better health outcomes among older adults with IBD, including a lower risk for RSV pneumonia.